Table 3.
Noninfarcted control (n=5) |
Vehicle-treated (n=10) |
CSC-treated (n=11) |
||
---|---|---|---|---|
IWTd (mm) | Before Cath | 9.84 ± 0.34 | 9.75 ± 0.43 | 8.50 ± 0.42 |
Final | 9.48 ± 0.73 | 9.19 ± 0.57 | 10.05 ± 0.38* | |
IWTs (mm) | Before Cath | 15.22 ± 0.79 | 12.15 ± 0.65 | 10.47 ± 0.59 |
Final | 15.28 ± 1.04 | 11.01 ± 0.66 | 13.28 ± 0.43* | |
PWTd (mm) | Before Cath | 10.69 ± 0.59 | 10.20 ± 0.54 | 10.07 ± 0.55 |
Final | 10.41 ± 0.71 | 9.57 ± 0.39 | 10.56 ± 0.52 | |
PWTs (mm) | Before Cath | 15.20 ± 1.16 | 14.03 ± 0.83 | 13.83 ± 0.67 |
Final | 15.18 ± 1.04 | 13.69 ± 0.74 | 14.88 ± 0.56 | |
PW ThF | Before Cath | 42.02 ± 6.57 | 37.44 ± 3.06 | 37.92 ± 2.68 |
(%) | Final | 47.11 ± 8.6 | 40.51 ± 2.66 | 42.32 ± 3.25 |
LVEDD | Before Cath | 33.44 ± 2.13 | 34.78 ± 1.63 | 35.42 ± 1.56 |
(mm) | Final | 36.53 ± 1.68 | 38.06 ± 2.36 | 35.73 ± 1.45 |
LVESD | Before Cath | 21.34 ± 1.55 | 25.63 ± 1.49 | 25.63 ± 1.31 |
(mm) | Final | 20.23 ± 1.55 | 28.76 ± 2.11 | 24.90 ± 1.38 |
FS (%) | Before Cath | 36.24 ± 2.12 | 26.5 ± 1.75 | 27.15 ± 1.53 |
Final | 44.44 ± 2.77 | 24.73 ± 1.51 | 30.68 ± 1.47* | |
FAC (%) | Before Cath | 48.83± 5.24 | 42.25 ± 2.09 | 45.18 ± 1.51 |
Final | 44.6 ± 2.97 | 40.55 ± 1.89 | 46.64 ± 2.07* | |
EDV (ml) | Before Cath | 46.74 ± 7.23 | 51.66 ± 5.26 | 53.92 ± 5.53 |
Final | 50.67 ± 2.17 | 65.16 ± 9.61 | 54.72 ± 5.38 |
Values are means±SEM. EDV, end-diastolic volume; FAC, fractional area change; FS, fractional shortening; IWTd, infarct wall thickness in diastole; IWTs, infarct wall thickness in systole; PW ThF, posterior wall thickening fraction; LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; PWTs, posterior wall thickness in systole; PWTd, posterior wall thickness in diastole.
P<0.05 vs. vehicle-treated group (unpaired t test).